Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer

Urology

Volumn 82, Issue 6, 2013, Pages 1370-1375

  Rehman, Shabnam ^a   Crane, Alice ^a   Din, Rakeeba ^a   Raza, Syed Johar ^a   Shi, Yi ^a   Wilding, Gregory ^a   Levine, Ellis G ^a   George, Saby ^a   Pili, Roberto ^a   Trump, Donald L ^a   Guru, Khurshid A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; COMORBIDITY; CONSULTATION; CYSTECTOMY; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PATIENT ABANDONMENT; PATIENT PREFERENCE; PATIENT REFERRAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; ROBOTICS; TREATMENT REFUSAL; TREND STUDY; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CHEMOTHERAPY, ADJUVANT; COMORBIDITY; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; REFUSAL TO TREAT; ROBOTICS; TREATMENT REFUSAL; URINARY BLADDER NEOPLASMS;

EID: 84888639023     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.07.055     Document Type: Article

References (24)

1. The American Cancer Society. Cancer Facts & Figures 2013. Available at: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/ index. Accessed July 16, 2013.
2. H.B. Grossman, R.B. Natale, and C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
3. G. Griffiths, R. Hall, and R. Sylvester International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial J Clin Oncl 29 2011 2171 2177
4. J. Lehmann, M. Retz, and C. Wiemers Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95) J Clin Oncol 23 2005 4963 4974
5. J. Lehmann, L. Franzaring, and J. Thüroff Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer BJU Int 97 2006 42 47
6. M. Stöckle, S. Wellek, and W. Meyenburg Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement Urology 48 1996 868 875
7. A. Feifer, J.M. Taylor, and M. Shouery Multi-institutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: phase I. Genitourinary Cancer Symposium Abstracts J Clin Oncol 29 suppl 7 2011 240
8. K.A. David, M.I. Milowsky, and J. Ritchey Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base J Urol 178 2007 451 454
9. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
10. C. Sternberg, P. de Mulder, J. Schornagel European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for Research and Treatment of Cancer Protocol no. 30924 J Clin Oncol 19 2001 2638 2646
11. International Bladder Cancer Nomogram Consortium B.H. Bochner, M.W. Kattan, and K.C. Vora Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer J Clin Oncol 20 2006 3967 3972
12. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists Lancet 354 1999 533 540
13. Hall RR; Intl Collaboration of Trialists of the MRC Advanced Bladder Cancer. Updated results of a randomized controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. In: Proceedings of the American Society of Clinical Oncology (ASCO '02), May 2002;21.
14. E. Scosyrev, E.M. Messing, and E. van Wijngaarden Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder Cancer 118 2012 72 81
15. G.V. Raj, S. Karavadia, and B. Schlomer Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer Cancer 117 2011 276 282
16. M.E. Nielsen, G.S. Palapattu, and P.I. Karakiewicz A delay in radical cystectomy of > 3 months is not associated with a worse clinical outcome BJU Int 100 2008 1015 1020
17. D. Pectasides, M. Pectasides, and M. Nikolaou Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review Eur Urol 48 2005 60 68
18. Advanced Bladder Cancer Meta-analysis Collaberation Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 2005 189 201
19. D.G. Skinner, J.R. Daniels, and C.A. Russell The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J Urology 145 1991 459 464
20. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 2005 189 199 discussion: 199-201
21. R.A. Scrimger, A.D. Murtha, and M.B. Parliament Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors Int J Radiat Oncol Biol Phys 51 2001 23 30
22. D. Schrag, N. Mitra, and F. Xu Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population Urology 65 2005 1118 1125
23. M. Burger, P. Mulders, and W. Witjes Use of neoadjuvant chemotherapy for muscle invasive bladder cancer is low among major European centers: results of a feasibility questionnaire Euro Urol 61 2012 1070 1071
24. D. Chung, K. Hersey, and N. Fleshner Differences between urologists in United States and Canada in approach to bladder cancer Urology 65 2005 919 925